ratiopharm GmbH Company Profile
ratiopharm is one of the leading international generics producer and in our home country Germany the top selling and most commonly prescribed pharmaceutical brand. We produce high quality medicines and sell them at low prices. By doing so, we contribute to cost containment in the healthcare sector.
With about 750 medicines, available exclusively from pharmacies, ratiopharm has one of the widest product ranges in the business. We sell 353 million pack units every year, meeting the needs of virtually all areas of medicine, from allergies to circulation problems and from gastroenteritis to toothaches.
Location
Graf-Arco-Straße 3
Ulm
89079
Germany
Contact
Phone: 49 731 402 02
Fax: 49 731 402 78 32
Email: info@ratiopharm.de
News Articles
ROUNDUP: Staatsanwaltschaft stellt Ratiopharm-Ermittlungen ein
Die Staatsanwaltschaft Ulm hat Ermittlungen gegen Verantwortliche der Pharmafirma Ratiopharm wegen umstrittener Zahlungen an niedergelassene Ärzte eingestellt. Das Unternehmen hatte diese am Umsat...
Ratiopharm Arena in Ulm/Neu-Ulm gegen Brasilien erstmals Davis Cup-Austragungsort
Hamburg (ots) - Die Ratiopharm Arena in Ulm Neu-Ulm ist zum ersten Male Austragungsort eines Davis Cup-Spiel. Vom 13 bis 15. September trifft die deutsche Tennis-Nationalmannschaft in Ulm/Neu-Ulm i...
Comparison of EPARs for G-CSF biosimilars approved in Europe
EMA approved its first biosimilar granulocyte colony-stimulating factor (G-CSF, filgrastim) for use in Europe back in 2008, since then, several biosimilar G-CSFs have been approved, including Biograst...
Pending EC decision: Memantine ratiopharm, memantine hydrochloride, Opinion date: 21-Mar-2013
Drugs and Medications
These highlights do not include all the information needed to use RISPERIDONE safely and effectively. See full prescribing information for RISPERIDONE.RISPERIDONE tabletsInitial U.S. Approval 1993
PubMed Articles
Presently available biosimilars in hematology-oncology: G-CSF.
Biopharmaceuticals were copies of endogenous human proteins developed in the mid-1990s that were characterized by complex three-dimensional, high-molecular weight compounds. What made them unique was...
Peripheral blood haematopoietic progenitor cell mobilization has become a standard procedure prior to autologous stem cell transplantation. Biosimilar granulocyte colony-stimulating factors (GCSF) hav...
Clinical Trials
None
Companies
ratiopharm is one of the leading international generics producer and in our home country Germany the top selling and most commonly prescribed pharmaceutical brand. We produce high quality medicines an...
On June 29, 2000, ratiopharm GmbH, Europe's largest generic drug company, purchased Technilab Pharma to establish ratiopharm's generic operations in Canada. Long before being acquired by ratiopharm Gm...
Die Merckle GmbH zählt zu den führenden Arzneimittelherstellern Europas. Zusammen mit dem Tochterunternehmen ratiopharm GmbH, der meistverwendeten und meistverordneten Arzneimittelmarke in Deutschla...
As a strategic start-up the BioGeneriX AG aims to develop bioengineered drugs for known targets. The unique character of BioGeneriX was moulded in a particular entrepreneurial setting within the exist...
More Information about "ratiopharm GmbH" on BioPortfolio
We have published hundreds of ratiopharm GmbH news stories on BioPortfolio along with dozens of ratiopharm GmbH Clinical Trials and PubMed Articles about ratiopharm GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ratiopharm GmbH Companies in our database. You can also find out about relevant ratiopharm GmbH Drugs and Medications on this site too.
